SLE and APS: ASA, LMW Heparin, or Both? episode artwork

EPISODE · Nov 13, 2022 · 20 MIN

SLE and APS: ASA, LMW Heparin, or Both?

from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls

Systemic Lupus Erythematosis is several-fold more common in women than in men. As it primarily targets reproductive age women, identification of and proper management of patients with associated antiphospholipid antibodies is crucial to improve maternal and neonatal outcomes. In this episode, we will review the 2019 ACR diagnostic criteria for SLE and review the management of SLE patients with/without antiphospholipid antibodies and with/without antiphospholipid antibody syndrome.

Episode metadata supplied by the publisher feed · Published Nov 13, 2022

Embed this episode

NOW PLAYING

SLE and APS: ASA, LMW Heparin, or Both?

0:00 20:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr. Chapa’s OBGYN Clinical Pearls?

This episode is 20 minutes long.

When was this Dr. Chapa’s OBGYN Clinical Pearls episode published?

This episode was published on November 13, 2022.

Can I download this Dr. Chapa’s OBGYN Clinical Pearls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!